PMID- 8135190
OWN - NLM
STAT- MEDLINE
DCOM- 19940418
LR  - 20190512
IS  - 0002-9173 (Print)
IS  - 0002-9173 (Linking)
VI  - 101
IP  - 3
DP  - 1994 Mar
TI  - Misleading hepatitis C serology following administration of intravenous 
      immunoglobulin.
PG  - 327-8
AB  - Intravenous immunoglobulin (IVIG) is a blood derivative that is being evaluated 
      for the prevention and treatment of numerous disorders. Recent studies have 
      suggested beneficial effects from the prophylactic administration of IVIG to 
      very-low-birth-weight neonates. A disadvantage of such therapy is misleading 
      infectious disease serologic assays following administration of IVIG. The authors 
      report a recent case in their neonatal intensive care unit of a 24-week 
      gestational age girl with a misleading positive hepatitis C serology reaction 
      following IVIG administration.
FAU - Nixon, R R
AU  - Nixon RR
AD  - Department of Pathology, Oregon Health Sciences University, Portland 97201-3042.
FAU - Smith, S A
AU  - Smith SA
FAU - Johnson, R L
AU  - Johnson RL
FAU - Pillers, D A
AU  - Pillers DA
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - England
TA  - Am J Clin Pathol
JT  - American journal of clinical pathology
JID - 0370470
RN  - 0 (Immunoglobulins)
SB  - IM
MH  - False Positive Reactions
MH  - Female
MH  - Hepatitis C/blood/*immunology
MH  - Humans
MH  - Immunoglobulins/*administration & dosage
MH  - *Infant, Low Birth Weight
MH  - Infant, Newborn
MH  - Injections, Intravenous
EDAT- 1994/03/01 00:00
MHDA- 1994/03/01 00:01
CRDT- 1994/03/01 00:00
PHST- 1994/03/01 00:00 [pubmed]
PHST- 1994/03/01 00:01 [medline]
PHST- 1994/03/01 00:00 [entrez]
AID - 10.1093/ajcp/101.3.327 [doi]
PST - ppublish
SO  - Am J Clin Pathol. 1994 Mar;101(3):327-8. doi: 10.1093/ajcp/101.3.327.